View of Nemolizumab Long-Term Safety and Efficacy up to 148 Weeks in the OLYMPIA Open-Label Extension Study in Patients with Prurigo Nodularis

Return to Article Details Nemolizumab Long-Term Safety and Efficacy up to 148 Weeks in the OLYMPIA Open-Label Extension Study in Patients with Prurigo Nodularis Download Download PDF